|
|
Corporate Profile: Dynavax
Technologies
| Summary: |
Dynavax Technologies
develops therapeutics from immunostimulatory sequences
(ISS), that can be artificially synthesized and mimic
the properties of bacterial DNAs in stimulating a
specific type of immune response. |
| Address (HQ):
|
2929 Seventh Street
Suite 100
Berkeley, CA 94710 |
| Phone #'s (HQ): |
Main |
(510) 848-5100 |
| Human Resources |
not known |
| Investor Relations |
(510) 665-4630 |
| Fax #'s (HQ): |
Main |
(510) 848-1327 |
| Human Resources |
(510) 848-1379 |
| Investor Relations |
(510) 848-1327 |
| Financial
information: |
| DVAX |
| Issued United States patents: |
Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
